PATH recently developed a mucosal immunization technology platform--viable in two formats--that builds on several proven formulation, adjuvant, and delivery technologies that enable the efficient sublingual administration of subunit vaccines. Part of PATH's Technology Updates series, this fact sheet describes their work on this new platform.

Author(s): PATH

Published: 2011

Resource types: PATH resource; Fact sheet

Diseases: Not disease/vaccine specific

Topics: Delivery technologies; Vaccine stabilization

Regions: Global